UniProtKB/Swiss-Prot Q13772: Variant p.Cys350Arg

Nuclear receptor coactivator 4
Gene: NCOA4
Feedback?

Variant information Variant position:

350 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Cysteine (C) to Arginine (R) at position 350 (C350R, p.Cys350Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and polar (C) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Sequence information Variant position:

350 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

614 The length of the canonical sequence.
Location on the sequence:

LLFQSYNVNDWLVKTDSCTN C QGNQPKGVEIENLGNLKCLN The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         LLFQ----SYNVNDWLVKTDSCTNCQGNQPKGVEIENLGNLKCLN

Mouse                         LLFQVFREPYNVSDWLVKPDSCTNCQGNQPRGVEIENLGNL

Zebrafish                     QIFKPFYESFSSSDWLSKSD-CGSCCATRTTAVEIENLGKL

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 614	Nuclear receptor coactivator 4
Alternative sequence	239 – 565	Missing. In isoform Beta.

Literature citations
Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform.
Alen P.; Claessens F.; Schoenmakers E.; Swinnen J.V.; Verhoeven G.; Rombauts W.; Peeters B.;
Mol. Endocrinol. 13:117-128(1999)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA AND BETA); VARIANTS LEU-94; LEU-154; ARG-350 AND PRO-561;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.